Physician

Apurva K Patel, MD

According to 2025 Medicare claims, Apurva Patel, MD (NPI: 1073770707) practices ophthalmology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is RETINA NORTHWEST P.C. (NPI: 1104813781; TIN: 930727712) and primary practice location at 98684-6951.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 18,336 HCPCS/CPT codes, and received $1,341,244 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 359 prescription claims across 105 beneficiaries totaling $41,126 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $17,396. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $571,093 to $1,341,244. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,851 and ending at $41,126. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$671K$1.3M2015 Medicare payment: $571,093 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $824,900 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $834,585 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $960,828 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,069,117 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,062,899 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,031,320 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,064,709 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,217,509 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,341,244 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154524,141$571,093
20165385,037$824,900
20175285,310$834,585
20185516,236$960,828
20195655,806$1,069,117
20205005,511$1,062,899
20214745,348$1,031,320
20224845,550$1,064,709
202349513,226$1,217,509
202456218,336$1,341,244

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$41K2015 Drug cost: $10,851 (USD; Tot_Drug_Cst)2016 Drug cost: $17,863 (USD; Tot_Drug_Cst)2017 Drug cost: $29,479 (USD; Tot_Drug_Cst)2018 Drug cost: $17,522 (USD; Tot_Drug_Cst)2019 Drug cost: $10,406 (USD; Tot_Drug_Cst)2020 Drug cost: $11,562 (USD; Tot_Drug_Cst)2021 Drug cost: $15,483 (USD; Tot_Drug_Cst)2022 Drug cost: $17,611 (USD; Tot_Drug_Cst)2023 Drug cost: $25,363 (USD; Tot_Drug_Cst)2024 Drug cost: $41,126 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581242$10,851
2016113368$17,863
2017127451$29,479
2018123403$17,522
2019124329$10,406
202092228$11,562
2021132324$15,483
2022137347$17,611
2023109376$25,363
2024105359$41,126

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2911,134$108
92014Established patient complete exam of visual system9799$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more325624$74
J7999Compounded drug, not otherwise classified174688$72
92134Imaging of retina5281,517$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1113,027$3,454
Bromfenac SodiumBromfenac Sodium11363$1,405
Ketorolac TromethamineKetorolac Tromethamine33994$863
OfloxacinOfloxacin491,146$523
Dorzolamide HclDorzolamide Hcl14600$367

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$661Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.2$16,735Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Apurva K. Patel, MD?

Tedicare shows public-source Medicare data for Apurva K. Patel, MD (NPI 1073770707), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Apurva K. Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Apurva K. Patel, MD?

Apurva K. Patel, MD is linked to RETINA NORTHWEST P.C. (billing NPI 1104813781) in the available physician profile data.

Does Apurva K. Patel, MD have Open Payments data?

Apurva K. Patel, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.